New York Times: March 19, 2019. With an overwhelmingly large number of women reporting adverse effects to their breast implants, collectively known as breast implant illness, the FDA finally agrees to review the devices.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
What Does Gottlieb’s Resignation Mean for Medtech?
Medtech: March 6, 2019. FDA Commissioner Scott Gottlieb sent in his resignation, but what does it mean for drug and device safety? NCHR President, Dr. Zuckerman, weighs in.
Read More »The Implant Files Sparked Reform Around The World. Here’s Why We’re Still Reporting.
ICIJ: February 27, 2019. The International Consortium of Investigative Journalists continue to scrutinize implants and their effect on people worldwide.
Read More »Double-Booked Surgeons: Study Raises Safety Questions For High-Risk Patients
NPR: February 26, 2019. A study shows that surgeons who leave the operating room before the surgery is over do not put the patient at a much greater risk.
Read More »Mother Who Got Breast Implants to Fix Her ‘Mom Bod’ Suffered Horrific Reaction
Daily Mail: February 21, 2019. A mother who got breast implants had such a severe autoimmune reaction that evaporated once the implants were removed.
Read More »